Thomas J O'Neill

8PUBLICATIONS
51CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCellular immunologyMedical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 12, 2026
MALT1 alternative splicing-A molecular rheostat for balancing immune activation and homeostasis.

|May 11, 2026
Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screens.

|Feb 11, 2026
Correction: Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependencies.

Valeria Soberón, Lena Osswald, Andrew Moore

|Jan 16, 2026
Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependencies.

Valeria Soberón, Lena Osswald, Andrew Moore

|Nov 10, 2025
LUBAC modulates CBM complex functions downstream of TRAF6 in T cells.

Carina Graß, Franziska Ober, Constanze Sixt

|May 09, 2025
MALT1 inhibitor MI-2 induces ferroptosis by direct targeting of GPX4.

Eikan Mishima, Thomas J O'Neill, Kai P Hoefig

Pageof 2

Frequent Collaborators

7 joint publications

Daniel Krappmann

2 joint publications

Thomas Seeholzer

2 joint publications

Andreas Gewies

2 joint publications

Gene Swinerd